The global intramuscular injector market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from chronic diseases such as diabetes and obesity, which are leading causes for intramuscular injections. In addition, the increasing number of surgical procedures and hospitalizations are also driving the growth of this market.
The global intramuscular injector market by type is segmented into prfillable injection system and fillable needle-free injectors. The prfillable injection system segment accounted for a share of over 50% in 2017 owing to its high usage in hospitals and clinics due to its ease-of-use features such as safety features, easy handling, low cost per use etc, whereas fillable needle-free injectors accounted for a share less than 10%. However, with technological advancements in needle free technology coupled with rising demand for self-injection devices among patients suffering from chronic diseases such as diabetes and obesity; it is expected that fillable needle free injectors will account for more than 50% by 2030.
The global intramuscular injector market by application includes hospitals, clinics & ambulatory surgery centers. Hospitals accounted for over 60% share in 2017 owing to their high usage rates due to their large patient population base; however it is expected that ambulatory surgery centers will account for more than 40% by 2030 owing to their growing adoption rates among healthcare providers due to their lower costs per use compared with hospitals.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the Intramuscular Injector market.
- Increasing awareness about the benefits of Intramuscular Injectors for patients with chronic diseases is also driving the growth of this market.
- The increasing number of geriatric population in developing countries such as China, India, and Brazil will drive the growth in this market.
- The high cost associated with Intramuscular Injectors will be a challenge for this market.
Industry Growth Insights published a new data on “Intramuscular Injector Market”. The research report is titled “Intramuscular Injector Market research by Types (Pre-fillable Injection System, Fillable Needle-free Injectors), By Applications (Hospitals, Clinics, Ambulatory Surgery Centers, Others), By Players/Companies Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation, Becton, Dickinson, Injex Pharma AG, Crossject SA, Solace Biotech, Sanify Healthcare Private Limited, Novosanis, Vata, Kaleo”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intramuscular Injector Market Research Report
By Type
Pre-fillable Injection System, Fillable Needle-free Injectors
By Application
Hospitals, Clinics, Ambulatory Surgery Centers, Others
By Companies
Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation, Becton, Dickinson, Injex Pharma AG, Crossject SA, Solace Biotech, Sanify Healthcare Private Limited, Novosanis, Vata, Kaleo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Intramuscular Injector Market Report Segments:
The global Intramuscular Injector market is segmented on the basis of:
Types
Pre-fillable Injection System, Fillable Needle-free Injectors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgery Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Antares Pharma
- Endo International Plc
- Bioject Medical Technologies
- PharmaJetMedical International Technology
- National Medical Products
- Valeritas
- European Pharma Group
- PenJet Corporation
- Becton
- Dickinson
- Injex Pharma AG
- Crossject SA
- Solace Biotech
- Sanify Healthcare Private Limited
- Novosanis
- Vata
- Kaleo
Highlights of The Intramuscular Injector Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pre-fillable Injection System
- Fillable Needle-free Injectors
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intramuscular Injector Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intramuscular injector is a device that is used to deliver medications into the muscle.
Some of the major companies in the intramuscular injector market are Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation, Becton, Dickinson, Injex Pharma AG, Crossject SA, Solace Biotech, Sanify Healthcare Private Limited, Novosanis, Vata, Kaleo.
The intramuscular injector market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intramuscular Injector Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intramuscular Injector Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intramuscular Injector Market - Supply Chain
4.5. Global Intramuscular Injector Market Forecast
4.5.1. Intramuscular Injector Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intramuscular Injector Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intramuscular Injector Market Absolute $ Opportunity
5. Global Intramuscular Injector Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intramuscular Injector Market Size and Volume Forecast by Type
5.3.1. Pre-fillable Injection System
5.3.2. Fillable Needle-free Injectors
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intramuscular Injector Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intramuscular Injector Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgery Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intramuscular Injector Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intramuscular Injector Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intramuscular Injector Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intramuscular Injector Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intramuscular Injector Demand Share Forecast, 2019-2026
9. North America Intramuscular Injector Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intramuscular Injector Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intramuscular Injector Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgery Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intramuscular Injector Market Size and Volume Forecast by Type
9.7.1. Pre-fillable Injection System
9.7.2. Fillable Needle-free Injectors
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intramuscular Injector Demand Share Forecast, 2019-2026
10. Latin America Intramuscular Injector Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intramuscular Injector Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intramuscular Injector Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgery Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intramuscular Injector Market Size and Volume Forecast by Type
10.7.1. Pre-fillable Injection System
10.7.2. Fillable Needle-free Injectors
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intramuscular Injector Demand Share Forecast, 2019-2026
11. Europe Intramuscular Injector Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intramuscular Injector Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intramuscular Injector Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgery Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intramuscular Injector Market Size and Volume Forecast by Type
11.7.1. Pre-fillable Injection System
11.7.2. Fillable Needle-free Injectors
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projctions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intramuscular Injector Demand Share, 2019-2026
12. Asia Pacific Intramuscular Injector Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intramuscular Injector Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intramuscular Injector Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgery Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intramuscular Injector Market Size and Volume Forecast by Type
12.7.1. Pre-fillable Injection System
12.7.2. Fillable Needle-free Injectors
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intramuscular Injector Demand Share, 2019-2026
13. Middle East & Africa Intramuscular Injector Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intramuscular Injector Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intramuscular Injector Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgery Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intramuscular Injector Market Size and Volume Forecast by Type
13.7.1. Pre-fillable Injection System
13.7.2. Fillable Needle-free Injectors
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intramuscular Injector Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intramuscular Injector Market: Market Share Analysis
14.2. Intramuscular Injector Distributors and Customers
14.3. Intramuscular Injector Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Antares Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Endo International Plc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bioject Medical Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PharmaJetMedical International Technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. National Medical Products
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Valeritas
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. European Pharma Group
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. PenJet Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Becton
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dickinson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Injex Pharma AG
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Crossject SA
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Solace Biotech
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Sanify Healthcare Private Limited
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Novosanis
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Vata
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Kaleo
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
